Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Flow Nasal Oxygen Therapy Re-evaluated from a Conceptual Point of View: Effect on Respiratory Effort and Lung Aeration After Extubation

NCT05652699 is registered in ClinicalTrials.gov with Henrik Endeman as lead sponsor.

NCT NCT05652699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05652699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Flow Nasal Oxygen Therapy Re-evaluated from a Conceptual Point of View: Effect on Respiratory Effort and Lung Aeration After Extubation
Lead sponsor
Henrik Endeman
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2022
Completion date
October 22, 2024
Enrollment
42 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

post extubation acute respiratory failure requiring reintubation, respiratory failure